Back to Brandywine Global Investment Management, LLC Brandywine Global Investment Management, LLC

AMRXAMRX

Showing 0 of 13 quarters

Position history for Brandywine Global Investment Management, LLCBrandywine Global Investment Management, LLC's holdings in Amneal Pharmaceuticals, Inc.

No. Brandywine Global Investment Management exited its AMRX (Amneal Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 414,084 shares worth $2.5M. Brandywine Global Investment Management first reported AMRX in Q4 2020 and held it in 11 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used